Common measurements for modified adeno-associated viruses (AAVs), a gene therapy delivery method, showed substantial ...

Roche has exercised its option to license a novel capsid from Dyno Therapeutics for use in a gene therapy program for an ...

Currently, the DMD treatment landscape includes Sarepta’s Elevidys (delandistrogene moxeparvovec), the first FDA-approved ...

Scientists looked at multiple techniques used to measure the modified viruses deployed in some gene therapy research and treatments. One technique, known as SEC-MALS, was the most precise and accurate ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...

4D Molecular Therapeutics is axing two clinical programs and cutting off funds for three other assets, with resources to be ...

Matika Bio partners with Childs Cure to develop gene therapy vectors for children Matika Bio collaborates with Childs Cure to ...

A Global Alliance to Save Lives58 How Two Parents and PackGene Are Redefining Whats Possible in Gene Therapy with Help from ...